Stock Price Movement and Market Context
On 12 Dec 2025, Entero Healthcare Solutions recorded an intraday low of Rs.984.1, representing a 2.28% decline during the trading session. This price level is the lowest the stock has touched in the past year, reflecting a downward trajectory over the last two consecutive trading days. Over this period, the stock has returned approximately -2.94%, underperforming its sector by 1.84% on the day.
The stock is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating sustained pressure on the price over multiple time horizons. This technical positioning suggests that the stock has been facing persistent selling interest relative to its recent historical levels.
In contrast, the broader market has shown resilience. The Sensex opened 232.90 points higher and was trading at 85,233.95, up 0.49% on the day. The index remains close to its 52-week high of 86,159.02, just 1.09% away, supported by bullish moving averages where the 50-day average is above the 200-day average. Mid-cap stocks have been leading the market gains, with the BSE Mid Cap index advancing by 0.82%.
Long-Term Performance and Comparative Analysis
Over the past year, Entero Healthcare Solutions has delivered a return of -32.18%, a stark contrast to the Sensex's positive 4.82% performance during the same period. The stock's 52-week high was Rs.1,564.95, highlighting the extent of the decline from its peak to the current low.
When compared to the BSE500 index, the stock has underperformed over the last three years, one year, and three months, indicating challenges in maintaining competitive returns within its peer group and the broader market.
This week's revealed pick, a Large Cap from Public Banks with TARGET PRICE, is already showing movement! Get the complete analysis before it's too late.
- - Target price included
- - Early movement detected
- - Complete analysis ready
Financial Metrics and Operational Highlights
Despite the stock's subdued price performance, Entero Healthcare Solutions has demonstrated notable financial metrics in recent periods. The company has reported net sales reaching Rs.1,570.95 crore in the latest quarter, the highest recorded to date. Operating profit margins have also shown strength, with operating profit to net sales at 3.95%, the highest quarterly figure recorded.
Profit before depreciation, interest, and taxes (PBDIT) for the quarter stood at Rs.62.06 crore, marking a peak in recent financial results. The company has declared positive results for seven consecutive quarters, indicating consistent profitability at the operational level.
Annual growth rates further illustrate this trend, with net sales expanding at approximately 30.10% per annum and operating profit growing at an annualised rate of 127.38%. These figures suggest a robust expansion in business scale and operational earnings over the longer term.
Balance Sheet and Valuation Considerations
Entero Healthcare Solutions maintains a low debt burden relative to earnings, with a Debt to EBITDA ratio of 1.33 times. This level indicates a manageable debt position in relation to the company’s earnings before interest, taxes, depreciation, and amortisation.
The company’s return on capital employed (ROCE) stands at 8.6%, reflecting the efficiency with which capital is utilised to generate earnings. The enterprise value to capital employed ratio is 2.3, suggesting a valuation that is attractive relative to the capital base.
Compared to its peers, the stock is trading at a discount to average historical valuations, which may reflect market caution given the recent price trends. Over the past year, while the stock price has declined by over 30%, profits have risen by 142%, resulting in a price-to-earnings-to-growth (PEG) ratio of 0.3, indicating earnings growth outpacing the stock price movement.
Shareholding and Institutional Interest
Institutional investors hold a significant stake in Entero Healthcare Solutions, accounting for 24.32% of the shareholding. This level of institutional ownership suggests that entities with substantial analytical resources maintain exposure to the company’s equity, despite the recent price pressures.
Why settle for Entero Healthcare Solutions ? SwitchER evaluates this Retailing small-cap against peers, other sectors, and market caps to find you superior investment opportunities!
- - Comprehensive evaluation done
- - Superior opportunities identified
- - Smart switching enabled
Summary of Price and Market Dynamics
The decline to Rs.984.1 marks a significant technical milestone for Entero Healthcare Solutions, as the stock trades well below all major moving averages and has recorded a notable loss over the past year. This contrasts with the broader market’s positive momentum, where indices such as the Sensex and mid-cap segments have shown gains.
While the company’s financial results indicate growth in sales and profits, the stock price has not reflected these fundamentals in recent months. The divergence between operational performance and market valuation highlights the complex dynamics influencing the stock’s price action.
Investors and market participants will continue to monitor the stock’s behaviour relative to sector trends and broader market movements as it navigates this low price territory.
Only ₹14,999 - Get MojoOne + Stock of the Week for 2 Years PLUS 6 Months FREE Claim 83% OFF →
